
    
      This study is to determine the optimal dose and evaluate safety and efficacy of Polyene
      Phosphatidylcholine S.C injection (AYP-101) for the reduction of Submental Fat (SMF) who wish
      improvement in the appearance of moderate to severe convexity or fullness associated with SMF
      in adults.
    
  